The Mets have been a different team since the All-Star Game and are playing a more fun, exciting brand of baseball since the Aug. 3 trade deadline. They are 26-21 since the unofficial second half began, and 19-12 since having their sell-off at the deadline.
Looking back a bit further, New York has a 31-28 record since June 30, meaning the club has had a two month-plus stretch that arguably shows what happened earlier this season (including a 12-game losing streak that helped derail their hopes) was likely an aberration.
But aberration or not, the Mets could not find enough success over the first three months of the year to save a season that began with World Series expectations. Blame for that lies mainly at the feet of president of baseball operations David Stearns, who oversaw an offseason of change that might have just been too much.
With the Mets excelling lately, a cynic could fairly say that the pressure is off. While that's true, it can be argued that lots of this turnaround has to do with players getting comfortable, gaining experience, and getting healthy, which could prove huge for a team that will likely return a large chunk of this core in 2027.
To highlight just a few...
Bo Bichette, who seemed a bit overwhelmed early as he adjusted to a new team and a huge market, has been himself since May 18. In 96 games since then, he is slashing .293/.340/.467 (.807 OPS) with 14 homers. While Bichette (who has opt-outs after this season and next) has yet to make a decision about his future, it would be relatively surprising if he opted out of a deal that will pay him $42 million in 2027.
After struggling for the first month as he acclimated to the majors, rookieCarson Benge (whose OPS entering play on April 22 was .416) has been a force. At the plate, he has a .798 OPS over his last 117 games. In right field, he's made highlight-reel plays routinely and displayed a cannon of an arm that rates at the very top of the sport.
Francisco Lindor missed two months due to a calf injury and has looked much more like himself since being back.
Christian Scottreturned from Tommy John surgery and cemented his rotation spot starting on May 1, helping to stabilize the starting staff along the way.

In a universe where Bichette and Benge didn't struggle so much out of the gate and Lindor didn't go down, this season likely would've gone very differently. But in this universe, the Mets are playing out the string.
Fortunately for them, this feels like a team that is a few tweaks (albeit relatively major ones) away from being right back in contention.
With that as a backdrop, here are five big storylines to watch down the stretch that could have an impact on how the roster is assembled ahead of 2027...
Jonah Tong and Zac Thornton
Following an up-and-down season in Triple-A Syracuse where he worked to implement a cutter, Tong impressed during his first big league start of the year, tossing five innings on Sept. 7 against the Marlins in Miami.
While Tong allowed four runs (all in the second inning), he showed the kind of composure he lacked in his big league stint in 2025. And his stuff (primarily his fastball-changeup combo) also played up, as Tong struck out seven and generated 16 swings and misses.
It's hard to envision a scenario where Tong does enough down the stretch to be viewed as a rotation member out of the gate in 2027, but he still possesses plenty of upside.
As far as Thornton, he has been excelling despite not-so-great metrics, showing moxie and often pitching relatively deep into games.
Thornton, who could be valuable rotation depth in 2027, has posted a 3.53 ERA in 12 starts this season while completing six innings or more six times.
How will Sean Manaea's Jekyll and Hyde season end?
It's been a tale of three seasons for Manaea.

He was relegated to the bullpen from Opening Day through June 7, as he struggled with reduced velocity following a 2025 season where he had an elbow issue.
From June 13 to Aug. 9, Manaea -- with his fastball sitting in the low-90s -- posted a 3.58 ERA in 61.2 innings over 11 starts, including a pair of largely dominant seven-inning performances.
Over his last four starts, Manaea has gotten hit hard, posting a 7.23 ERA (6.60 FIP) in 23.2 innings while surrendering 30 hits (including seven home runs).
A few weeks ago, it seemed safe to put Manaea's name down in ink when it came to a spot in the 2027 rotation. Now, it can be argued that it's in pencil.
Who are the keepers in the remade bullpen?
Somewhat implausibly, the Mets traded four stalwarts of their 2026 bullpen at the deadline (Luke Weaver, Huascar Brazoban, Brooks Raley, and A.J. Minter) and found themselves with a relief corps that's arguably better.
With Devin Williams on the IL, Kodai Senga assumed the closer role shortly after being turned into a high-leverage reliever. Using primarily his four-seam fastball and ghost fork, Senga has been terrific since becoming a short reliever, posting a 1.46 ERA in 12.1 innings while fanning 13.
The Mets haven't yet decided what Senga's role will be in 2027, and it bears watching when it comes to whether his body can handle the rigors of regular relief use.
Rookie left-hander Nate Lavender -- whose elite extension leads to his pitches kind of jumping at hitters -- has yet to allow a run over his first 13.0 big league innings, posting a 0.61 WHIP along the way. Barring a surprise, he has all but secured a spot in the 2027 'pen.
Daniel Duarte has also opened eyes, with a 2.00 ERA and 0.74 WHIP in 27.0 innings while allowing only 14 hits. Duarte, like Lavender, missed most of the last two seasons due to elbow surgery.

The Marcus Semien situation
Since returning from a hip injury on July 18 (a malady he played through for a while and probably hampered his production), Semien has been a bit better.
At the dish, he has posted a .676 OPS (it was .613 when he landed on the IL).
In the field, Semien has been smoother and rangier, displaying the kind of defensive prowess that won him a Gold Glove with the Rangers in 2025.
If Semien can simply be a league average hitter, keeping him in the lineup regularly in 2027 would be justifiable. If not, the arrival of a prospect like Jefferson Rojas or Mitch Voit could happen quickly, potentially turning Semien into a very expensive bench player.
Who's on first?
Given how their roster is constituted, it's possible the only way the Mets can seriously improve their offense for next season is by adding a first baseman and/or designated hitter.
To that end, how sold are they on Jared Young as a potential long end of a first base platoon?
Young has posted a .796 against right-handers this season, but just .606 against lefties.
Mark Vientos, whose return from injury was preceded by some relatively pointed comments by interim manager Andy Green, has slugged two homers in five games since returning. But his defense at first base has remained an issue.
Then there's Brett Baty, whose offensive production has ticked up since Aug. 21, with him posting a 1.101 OPS in 36 plate appearances over his last 14 games.

















